195 related articles for article (PubMed ID: 18793340)
1. Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
Mason JM; Raghunath AS; Hungin AP; Jackson W
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1297-303. PubMed ID: 18793340
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care: a randomized controlled trial.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2007 Mar; 25(5):585-92. PubMed ID: 17305759
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.
Kajihara Y; Shimoyama T; Mizuki I
Scand J Gastroenterol; 2017 Feb; 52(2):238-241. PubMed ID: 27806639
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the dyspeptic patient: a cost-utility study.
Ebell MH; Warbasse L; Brenner C
J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
[TBL] [Abstract][Full Text] [Related]
7. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
[TBL] [Abstract][Full Text] [Related]
9. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
[TBL] [Abstract][Full Text] [Related]
10. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan.
Sasaki M; Ogasawara N; Utsumi K; Kamiya T; Kataoka H; Tanida S; Mizoshita T; Shimura T; Hirata Y; Kasugai K; Joh T
Methods Find Exp Clin Pharmacol; 2010 May; 32(4):243-6. PubMed ID: 20508872
[TBL] [Abstract][Full Text] [Related]
12. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
13. Does pretreatment with lansoprazole influence Helicobacter pylori eradication rate and quality of life?
Inoue M; Okada H; Hori S; Kawahara Y; Kawano S; Takenaka R; Toyokawa T; Onishi Y; Shiratori Y; Yamamoto K
Digestion; 2010; 81(4):218-22. PubMed ID: 20090337
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.
Chiba N; Veldhuyzen Van Zanten SJ; Escobedo S; Grace E; Lee J; Sinclair P; Barkun A; Armstrong D; Thomson AB
Aliment Pharmacol Ther; 2004 Feb; 19(3):349-58. PubMed ID: 14984382
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).
Delaney BC; Qume M; Moayyedi P; Logan RF; Ford AC; Elliott C; McNulty C; Wilson S; Hobbs FD
BMJ; 2008 Mar; 336(7645):651-4. PubMed ID: 18310262
[TBL] [Abstract][Full Text] [Related]
16. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
17. Yields of dual therapy containing high-dose proton pump inhibitor in eradication of H. pylori positive dyspeptic patients.
Ince AT; Tozlu M; Baysal B; Şentürk H; Arıcı S; Özden A
Hepatogastroenterology; 2014; 61(133):1454-8. PubMed ID: 25436324
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
Mazzoleni LE; Sander GB; Ott EA; Barros SG; Francesconi CF; Polanczyk CA; Wortmann AC; Theil AL; Fritscher LG; Rivero LF; Cartell A; Edelweiss MI; Uchôa DM; Prolla JC
Dig Dis Sci; 2006 Jan; 51(1):89-98. PubMed ID: 16416218
[TBL] [Abstract][Full Text] [Related]
19. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Suzuki H; Masaoka T; Sakai G; Ishii H; Hibi T
J Gastroenterol Hepatol; 2005 Nov; 20(11):1652-60. PubMed ID: 16246181
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]